Activating PIK3CD mutations impair human cytotoxic lymphocyte differentiation and function and EBV immunity
Emily S.J. Edwards(Jeffrey Modell Foundation), Stuart G. Tangye(Garvan Institute of Medical Research), Paul Gray(UNSW Sydney), Peter Hsu(The University of Sydney), Julia Bier(Garvan Institute of Medical Research), Anthony Lau(Garvan Institute of Medical Research), Theresa Cole(Royal Children's Hospital), Isabelle Meyts(KU Leuven), Kaan Boztuǧ(Forschungszentrum Jülich), Steven M. Holland(National Institute of Allergy and Infectious Diseases), Elissa K. Deenick(Garvan Institute of Medical Research), Lucinda J. Berglund(Westmead Hospital), Emma Gostick(University Hospital of Wales), David A. Price(University Hospital of Wales), Melanie Wong, Gülbû Uzel(National Institutes of Health), Sharon Choo(Royal Children's Hospital), Michael O’Sullivan(United States Government Publishing Office)
Cited by 95
Related Papers
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
|Nature Medicine|2006|3.6k
A human memory T cell subset with stem cell–like properties
|Nature Medicine|2011|2k
CD4+ T Cell Depletion during all Stages of HIV Disease Occurs Predominantly in the Gastrointestinal Tract
|The Journal of Experimental Medicine|2004|1.8k
Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation
|Journal of Immunological Methods|2003|1.6k